Spencer S. Eccles Health Sciences Library, University of Utah
Abstract
Diagnosing Giant Cell Arteritis (GCA) is based on clinical symptoms, signs, labs and temporal artery biopsy (TAB) pathology.(1-4) Biopsies are the gold standard for confirming GCA.(1,3) Recently, a revised American College of Rheumatology (rACR) criteria was proposed with a more extensive set of criteria, which included biopsy.(2) A clinical tool without biopsy was created to stratify patients according to GCA risk.(1) The purpose of this study is to analyze our patient population with temporal artery biopsies according to the proposed rACR clinical criteria and to examine how (i)TABs and (ii) the final diagnosis regardless of biopsy correlated to this clinical suspicion
